Scinai Immunotherapeutics Ltd. American Depositary Shares

SCNI XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

1.9M

Short interest (May 15)

4.5%

Net Short (Jun 03 ): -1.0%

Borrow Fee

225.99%

↓ 64.4%

Available Shares

300K

↑ 68.7%

Price Chart

Company Overview

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001611747

Asset Type: ADRC

Market Data

Market Cap: $1,896,740

Employees: 45

Status: Active

Short Interest

Current Borrow Fee 225.99%

Range: 209.90% - 229.19%

Available Shares 300K

Range: 200K - 300K

Recent Changes

Fee Change: ↓ 10.3%

Available Change: ↑ 44.4%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime